So, You Want to Repurpose a Drug - Now What?
Join us to hear from and question Dr. Daniel Keene on his perspectives on designing appropriate trials for drug repurposing and the role academic and clinician researchers (can) play in evaluating drug safety and efficacy.
Dr. Daniel Keene is the associate director of the Office of Clinical Trials at the Pharmaceutical Drug Directorate at Health Canada.
After obtaining his medical degree from the University of Saskatchewan, he completed his post-graduate medical training in pediatrics at the Hospital for Sick Children in Toronto, and neurology at the Montreal Neurological Institute. He is a fellow of the Royal College of Physicians and Surgeons of Canada with speciality certification in both pediatrics and neurology. In addition, he has obtained a Master of Arts in Public Policy from Carleton University and a Graduate Certificate in Academic Excellence in Epidemiology form the School of Public Health, University of Michigan.
Prior to coming to Health Canada, he was an active member of the Medical Faculty at the University Ottawa in the Departments of Pediatrics and Medicine, and Senior Clinical Investigator at the Children’s Hospital of Eastern Ontario. He has authored over a 100-peer reviewed scientific articles on variety of topics including identification of pediatric neurological disorders, neuro-oncology, epidemiology and health policy; as well as contributing to several sentinel medical textbooks in these areas.
